Trials / Conditions / CYP2C19 Polymorphism
CYP2C19 Polymorphism
6 registered clinical trials studyying CYP2C19 Polymorphism — 3 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | Implementation of Onsite Rapid CYP2C19 Assay for Genotype Guided Dual Antiplatelet Therapy After Acute Ischemi NCT06292117 | University of Virginia | — |
| Recruiting | CYP2C19 Genotype-Guided P2Y12 Receptor Inhibitor Selection After Complex Percutaneous Coronary Intervention NCT06283888 | Zunyi Medical College | Phase 4 |
| Recruiting | POPular GUILTY PILOT: Genotype-guided Clopidogrel Monotherapy NCT05926271 | St. Antonius Hospital | Phase 2 |
| Completed | Clinical and Genetic Influencing Factors on Clozapine Pharmacokinetics NCT04240496 | University of Monastir | N/A |
| Unknown | The Influence of Gene Polymorphism on Clinical Outcomes in Patients Undergoing PCI NCT03758248 | Beijing Anzhen Hospital | — |
| Completed | Effect of the CYP2C19 Polymorphism in Helicobacter Pylori Eradication NCT03650543 | Javeriana University | Phase 4 |